Unjoni Ewropea -
Ungeriż -
EMA (European Medicines Agency)
zokinvy
eigerbio europe limited - lonafarnib - progeria; laminopathies - egyéb táplálkozási traktus pedig anyagcsere termékek, - zokinvy is indicated for the treatment of patients 12 months of age and older with a genetically confirmed diagnosis of hutchinson-gilford progeria syndrome or a processing-deficient progeroid laminopathy associated with either a heterozygous lmna mutation with progerin-like protein accumulation or a homozygous or compound heterozygous zmpste24 mutation.
